Konrad Sandhoff
Affiliations: | 1979- | Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Nordrhein-Westfalen, Germany |
Area:
Lipid biochemistryWebsite:
https://www.limes-institut-bonn.de/en/research/research-departments/unit-3/sandhoff-lab/people/lab-head/#c5876Google:
"Konrad Sandhoff"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Athanassios Giannis | grad student | 1986 | Universität Bonn |
| Christoph Arenz | post-doc | 2001-2004 | Universität Bonn |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lopergolo D, Berti G, Mari F, et al. (2022) A case of spastic paraplegia type 11 mimicking a GM2-gangliosidosis. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 43: 2849-2852 |
| Breiden B, Sandhoff K. (2021) Corrigendum to: Emerging mechanisms of drug-induced phospholipidosis. Biological Chemistry |
| Sandhoff K. (2021) Secondary ganglioside GM2 accumulation in mucopolysaccharidoses. Molecular Genetics and Metabolism Reports. 28: 100789 |
| Breiden B, Sandhoff K. (2021) Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism. International Journal of Molecular Sciences. 22 |
| Breiden B, Sandhoff K. (2020) Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease. International Journal of Molecular Sciences. 21 |
| Sen NE, Arsovic A, Meierhofer D, et al. (2019) In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism. International Journal of Molecular Sciences. 20 |
| Breiden B, Sandhoff K. (2019) Emerging mechanisms of drug-induced phospholipidosis. Biological Chemistry |
| Breiden B, Sandhoff K. (2019) Lysosomal Glycosphingolipid Storage Diseases. Annual Review of Biochemistry. 88: 461-485 |
| Anheuser S, Breiden B, Sandhoff K. (2019) Ganglioside GM2 catabolism is inhibited by storage compounds of mucopolysaccharidoses and by cationic amphiphilic drugs. Molecular Genetics and Metabolism |
| Anheuser S, Breiden B, Sandhoff K. (2019) Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles. Journal of Lipid Research. 60: 1099-1111 |